Sangamo BioSciences | Aktywa





Aktywa Zmiana Data
Alaunos Therapeutics USD 3.72M 1.01M 2025-09
Alnylam Pharmaceuticals USD 4.85B 285.64M 2025-09
Alterity Therapeutics Limited AUD 27.32M 6.07M 2023-06
Amgen USD 90.59B 445M 2025-12
Bayer EUR 104.21B 1.03B 2025-09
BioCryst Pharmaceuticals USD 446.42M 10.76M 2025-09
Biogen USD 29.44B 232M 2025-12
BioMarin Pharmaceutical USD 7.61B 158.53M 2025-09
Cipla INR 401.64B 27.77B 2025-09
Clal Biotechnology ILS 158.39M 24.3M 2023-12
Compugen USD 97.84M 8.68M 2025-09
CSL USD 39.4B 957M 2025-06
Gilead Sciences USD 58.53B 2.81B 2025-09
GlaxoSmithKline GBP 61.12B 221M 2025-12
Grifols EUR 23.29B 3.35M 2025-09
Ionis Pharmaceuticals USD 3.03B 47.96M 2025-09
J&J USD 192.82B 573M 2025-09
Karyopharm Therapeutics USD 96.23M 8.65M 2025-09
Merck USD 129.55B 12.02B 2025-09
Novartis USD 107.29B 2.89B 2025-09
Omeros USD 200.57M 34.59M 2025-06
Pfizer USD 208.73B 2.64B 2025-09
Roche Holding CHF 100.7B 5.94B 2025-12
Sangamo BioSciences USD 97.56M 11.39M 2025-06
Sanofi EUR 126.81B 2.99B 2025-12
Sarepta Therapeutics USD 3.49B 186.38M 2025-09
Tectonic Therapeutic USD 277M 18.31M 2025-09
Ultragenyx Pharmaceutical USD 1.19B 115.82M 2025-09
Vertex Pharmaceuticals USD 24.86B 825.6M 2025-09


Sangamo BioSciences Aktywa - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Feb 2026.